利用 HLA-Glyco 揭示糖基化免疫肽组。
Unraveling the glycosylated immunopeptidome with HLA-Glyco.
机构信息
International Centre for Cancer Vaccine Science, University of Gdansk, Gdansk, Poland.
Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
出版信息
Nat Commun. 2023 Jun 12;14(1):3461. doi: 10.1038/s41467-023-39270-2.
Recent interest in targeted therapies has been sparked by the study of MHC-associated peptides (MAPs) that undergo post-translational modifications (PTMs), particularly glycosylation. In this study, we introduce a fast computational workflow that merges the MSFragger-Glyco search algorithm with a false discovery rate control for glycopeptide analysis from mass spectrometry-based immunopeptidome data. By analyzing eight large-scale publicly available studies, we find that glycosylated MAPs are predominantly presented by MHC class II. Here, we present HLA-Glyco, a comprehensive resource containing over 3,400 human leukocyte antigen (HLA) class II N-glycopeptides from 1,049 distinct protein glycosylation sites. This resource provides valuable insights, including high levels of truncated glycans, conserved HLA-binding cores, and differences in glycosylation positional specificity between HLA allele groups. We integrate the workflow within the FragPipe computational platform and provide HLA-Glyco as a free web resource. Overall, our work provides a valuable tool and resource to aid the nascent field of glyco-immunopeptidomics.
最近,人们对靶向治疗产生了浓厚的兴趣,这是由于对 MHC 相关肽(MAP)的研究取得了进展,这些 MAP 经历了翻译后修饰(PTMs),特别是糖基化。在这项研究中,我们引入了一种快速计算工作流程,该流程将 MSFragger-Glyco 搜索算法与基于质谱的免疫肽组数据中糖肽分析的假发现率控制相结合。通过分析八个大型公开可用的研究,我们发现糖基化的 MAP 主要由 MHC 类 II 呈现。在这里,我们提出了 HLA-Glyco,这是一个包含超过 3400 个人白细胞抗原(HLA)类 II N-糖肽的综合资源,这些糖肽来自 1049 个不同的蛋白质糖基化位点。该资源提供了有价值的见解,包括高水平的截断聚糖、保守的 HLA 结合核心以及 HLA 等位基因组之间糖基化位置特异性的差异。我们将工作流程集成到 FragPipe 计算平台中,并提供 HLA-Glyco 作为免费的网络资源。总的来说,我们的工作为新兴的糖免疫肽组学领域提供了有价值的工具和资源。
相似文献
Nat Commun. 2023-6-12
Nat Methods. 2020-11
Mol Cell Proteomics. 2022-3
J Chromatogr B Analyt Technol Biomed Life Sci. 2023-8-1
引用本文的文献
Nat Struct Mol Biol. 2025-2-10
Explor Target Antitumor Ther. 2024
Anal Bioanal Chem. 2025-2
Front Immunol. 2023
Nucleic Acids Res. 2024-1-5
本文引用的文献
Mol Cell Proteomics. 2022-3